Get started Log in

RX — Biosyent Share News

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapHigh Flyer

Market Cap
CA$193.87m
Enterprise Value
CA$188.07m
Revenue
CA$43.05m

Brief: Biosyent Announces Introduction Of New Feramax® Pd
05/10/2020 13:34
Brief: Biosyent Signs Exclusive Agreement For New WomenS Health Product
01/10/2020 14:26
Brief: Biosyent Inc Q2 Earnings Per Share C$0.06
26/08/2020 12:41
Brief: Biosyent Announces The Availability Of Tibella® In Canada
29/07/2020 21:19
Brief: Biosyent Reports Q1 Earnings Per Share Of C$0.11
28/05/2020 13:06
Brief: Biosyent Announces Adoption Of Restricted Share Unit Plan
06/03/2020 22:36
Brief: Biosyent Inc Says Has Signed An Exclusive License And Supply Agreement With Aft Pharmaceuticals
25/11/2019 23:27
Brief: Biosyent Q3 Earnings Per Share C$0.11
20/11/2019 14:40
Brief: Biosyent Posts Q2 EPS Of C$0.05
23/08/2019 13:45
Brief: Biosyent Announces Withdrawal Of Health Canada Submissions For Cardiovascular Products
26/06/2019 13:19
Brief: Biosyent Q1 Earnings Per Share C$0.07
29/05/2019 14:44
Brief: BioSyent Says Health Canada Has Approved Tibella
13/05/2019 22:41
Brief: BioSyent Announces Notice Of Deficiency For Cardiovascular Products
22/03/2019 22:07
Brief: Biosyent Reports Q4 EPS AT C$0.11
20/03/2019 12:09
Brief: Biosyent Announces Normal Course Issuer Bid
04/12/2018 13:58
Brief: Biosyent Releases Results For Third Quarter 2018
21/11/2018 13:09
Brief: Biosyent Inc Says Alfred D'souza Has Retired As Chief Financial Officer
10/09/2018 23:19
Brief: Biosyent Q2 Earnings Per Share C$0.11
22/08/2018 13:29
Brief: Biosyent Reports Q1 Earnings Per Share C$0.08
30/05/2018 13:15
Brief: BioSyent Q4 Earnings Per Share C$0.10
21/03/2018 12:10